Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli

Immunology

Volumn 118, Issue 4, 2006, Pages 509-519

  Schauber, Jürgen ^a   Dorschner, Robert A ^a   Yamasaki, Kenshi ^a   Brouha, Brook ^a   Gallo, Richard L ^a  

^a Mail Code 151 ^*

Author keywords

Cathelicidin; Colon mucosa; Defensin; Gene regulation; Human; Skin

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 2; BUTYRIC ACID; CATHELICIDIN; COLECALCIFEROL;

ANTIMICROBIAL ACTIVITY; ARTICLE; CELL TYPE; COLON MUCOSA; CONTROLLED STUDY; EPITHELIUM CELL; GENE ACTIVATION; GENE ACTIVITY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; INNATE IMMUNITY; KERATINOCYTE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION REGULATION;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; BETA-DEFENSINS; BLOTTING, WESTERN; BUTYRATES; CELLS, CULTURED; CHOLECALCIFEROL; COLITIS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, NATURAL; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MONOCYTES; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN DISEASES, BACTERIAL; TRANSFECTION;

EID: 33746087225     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02399.x     Document Type: Article

References (35)

1. Gallo RL. Antimicrobial Peptides in Human Health and Disease. Norwich: U.K. Horizon Press, 2005.
2. De Y, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000; 192:1069-74.
3. Zaiou M, Gallo RL. Cathelicidins, essential gene-encoded mammalian antibiotics. J Mol Med 2002; 80:549-61.
4. Selsted ME, Ouellette AJ. Mammalian defensins in the antimicrobial immune response. Nat Immunol 2005; 6:551-7.
5. Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 1996; 238:325-32.
6. Sorensen OE, Gram L, Johnsen AH et al. Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina. J Biol Chem 2003; 278:28540-6.
7. Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J Immunol 2004; 172:3070-7.
8. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997; 387 (6636):861.
9. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, Kagnoff MF. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163:6718-24.
10. Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002; 70:953-63.
11. Schauber J, Svanholm C, Termén S et al. The expression of the cathelicidin LL-37 is modulated by short-chain fatty acids in colonocytes: relevance of signalling pathways. Gut 2003; 52:743-51.
12. Dorschner RA, Pestonjamasp VK, Tamakuwala S et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 2001; 117:91-7.
13. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347:1151-60.
14. Hase K, Murakami M, Iimura M et al. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 2003; 125:1613-25.
15. Wehkamp J, Harder J, Weichenthal M et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004; 53:1658-64.
16. Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B, Gudmundsson G. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 2001; 7:180-5.
17. Wang T-T, Nestel F, Bourdeau V et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173:2909-12.
18. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. Faseb J 2005; 19:1067-77.
19. Weber G, Heilborn JD, Chamorro Jimenez CI, Hammarsjo A, Torma H, Stahle M. Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 2005; 124:1080-2.
20. Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu L, Ganz T, Borregaard N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 2003; 170:5583-9.
21. Harder J, Meyer-Hoffert U, Wehkamp K, Schwichtenberg L, Schroder JM. Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 2004; 123:522-9.
22. Braff MH, Zaiou M, Fierer J, Nizet V, Gallo RL. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect Immun 2005; 73:6771-81.
23. Prinzen C, Muller U, Endres K, Fahrenholz F, Postina R. Genomic structure and functional characterization of the human ADAM10 promoter. Faseb J 2005; 19:1522-4.
24. Lee PH, Ohtake T, Zaiou M, Murakami M, Rudisill JA, Lin KH, Gallo RL. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc Natl Acad Sci USA 2005; 102:3750-5.
25. Peschel A, Jack RW, Otto M et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with 1-lysine. J Exp Med 2001; 193:1067-76.
26. Bikle DD. Vitamin D regulated keratinocyte differentiation. J Cell Biochem 2004; 92:436-44.
27. Pütsep K, Carlsson G, Boman H, Andersson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002; 360:1144-9.
28. Cole AM, Shi J, Ceccarelli A, Kim YH, Park A, Ganz T. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 2001; 97:297-304.
29. Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DY. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol 2004; 172:1763-7.
30. Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol 2005; 174:4901-7.
31. Morrison GM, Davidson DJ, Dorin JR. A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide. FEBS Lett 1999; 442:112-16.
32. Nizet V, Ohtake T, Lauth X et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414 (6862):454-7.
33. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 1994; 35 (1 Suppl.):S35-8.
34. Mallbris L, Wiegleb Edstrom D, Sundblad L, Granath F, Stahle M. UVB upregulates the antimicrobial protein hCAP18 mRNA in human skin. J Invest Dermatol 2005; 125:1072-4.
35. Dorschner RA, Lopez-Garcia B, Peschel A et al. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J 2006; 20:35-42.